[回归冠心病患者的工作:RTT法国多中心研究]
Bruno Pavy1, Marie-Christine Iliou2, Sophie Péclet3
1centre hospitalier Loire-Vendée-Océan, Machecoul, France.
概括
对于大多数患者来说,急性冠状动脉综合征 (ACS) 后恢复工作是可以实现的,但延迟仍然存在. 改善对心脏康复的准入和探索远程康复可以帮助患者更快地回到工作位.
科学领域:
- 心脏病学 心脏病学
- 职业健康 职业健康 职业健康
- 公共卫生 公共卫生
背景情况:
- 冠心病 (CHD) 显著影响发病率,死亡率和社会成本.
- 对患有心脏病的患者来说,恢复工作至关重要.
- 法国有限且过时的数据需要对回归工作率进行最新的研究.
研究的目的:
- 更新法国急性冠状动脉综合征 (ACS) 后恢复工作的数据.
- 确定影响工作回归率和时间的因素.
- 为改善心脏病患者重新入职工作的战略提供信息.
主要方法:
- 一项多中心研究,涉及经历过ACS并且正在工作的患者.
- 通过有关病理学,职业和工作计划的问卷收集的数据.
- 在6个月的后续访谈中分析了临床和职业情况.
主要成果:
- 观察到81%的返回工作率,其中93%的人回到以前的职位.
- 不返回的关键因素包括左心室射出分数的减少,心痛,心力衰竭和苛刻的职业条件 (轮班工作,寒冷暴露,强制工作率).
- 延迟康复准入,重负荷,不良姿势,以及缺乏患者/医生项目规划,延长了返回工作时间.
结论:
- 在ACS后的返回工作率保持稳定,但返回工作的时间相当大.
- 建议加强对心脏康复的准入,包括远程康复.
- 优化康复可以改善患者的治疗结果和经济效益.
相关概念视频
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...


